IFC Holdings’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-16,950
Closed -$217K 525
2017
Q2
$217K Sell
16,950
-65,300
-79% -$872K 0.02% 445
2017
Q1
$1.06M Buy
82,250
+600
+0.7% +$7.58K 0.09% 146
2016
Q4
$813K Sell
81,650
-16,650
-17% -$182K 0.08% 170
2016
Q3
$1.18M Buy
98,300
+2,800
+3% +$28.6K 0.12% 117
2016
Q2
$885K Buy
95,500
+5,600
+6% +$55.3K 0.1% 142
2016
Q1
$888K Buy
89,900
+5,750
+7% +$54.1K 0.11% 129
2015
Q4
$1.45M Buy
+84,150
New +$1.34M 0.19% 89

Other funds holding HALO

IFC Holdings's HALO Position: Q3 2017 in Review

IFC Holdings sold out of Halozyme (HALO) in Q3 2017, closing a stake of 16,950 shares — an estimated $217K sold.

IFC Holdings first reported a position in HALO in Q4 2015 and held it in 7 quarters. The position peaked at $1.45M in Q4 2015. 166 funds tracked by Wall St. Rank hold HALO as of Q3 2017.

  • IFC Holdings reported no remaining Halozyme position as of Q3 2017 after selling out during the quarter.
  • IFC Holdings sold 16,950 Halozyme shares in Q3 2017, an estimated $217K.
  • IFC Holdings first reported a position in Halozyme in Q4 2015 and held it in 7 quarters.
  • IFC Holdings's Halozyme position peaked at $1.45M in Q4 2015.
  • 166 funds tracked by Wall St. Rank held Halozyme as of Q3 2017.

Based on IFC Holdings's 13F filing for Q3 2017, filed 26 Oct 2017.